The tyrosine kinase inhibitor nilotinib targets the discoidin domain receptor DDR2 in calcific aortic valve stenosis.
Carracedo M, Pawelzik SC, Artiach G, Pouwer MG, Plunde O, Saliba-Gustafsson P, Ehrenborg E, Eriksson P, Pieterman E, Stenke L, Princen HMG, Franco-Cereceda A, Bäck M.
Carracedo M, et al. Among authors: back m.
Br J Pharmacol. 2022 Oct;179(19):4709-4721. doi: 10.1111/bph.15911. Epub 2022 Jul 19.
Br J Pharmacol. 2022.
PMID: 35751904
Free PMC article.